172 related articles for article (PubMed ID: 19246880)
1. Fluorine-18 fluorodeoxyglucose with positron emission tomography revealed bone marrow involvement in sarcoidosis patients with anaemia.
de Prost N; Kerrou K; Sibony M; Talbot JN; Wislez M; Cadranel J
Respiration; 2010; 79(1):25-31. PubMed ID: 19246880
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M
Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205
[TBL] [Abstract][Full Text] [Related]
3. Bone Marrow Sarcoidosis with Pancytopenia and Renal Failure Presenting as Fever of Unknown Origin: The Pivotal Role of 18F-FDG PET/CT in Lesion Detection.
Matsuda N; Iida S; Ogino Y; Saito N; Yasutake M
J Nippon Med Sch; 2021 May; 88(2):145-148. PubMed ID: 32741905
[TBL] [Abstract][Full Text] [Related]
4. F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients.
Mostard RL; Prompers L; Weijers RE; van Kroonenburgh MJ; Wijnen PA; Geusens PP; Drent M
Clin Nucl Med; 2012 Jan; 37(1):21-5. PubMed ID: 22157023
[TBL] [Abstract][Full Text] [Related]
5. Granulomatous lesions in bone marrow: clinicopathologic findings and significance in a study of 48 cases.
Brackers de Hugo L; Ffrench M; Broussolle C; Sève P
Eur J Intern Med; 2013 Jul; 24(5):468-73. PubMed ID: 23414770
[TBL] [Abstract][Full Text] [Related]
6. Intraocular sarcoidosis: association of clinical characteristics of uveitis with findings from 18F-labelled fluorodeoxyglucose positron emission tomography.
Rahmi A; Deshayes E; Maucort-Boulch D; Varron L; Grange JD; Kodjikian L; Seve P
Br J Ophthalmol; 2012 Jan; 96(1):99-103. PubMed ID: 21464036
[TBL] [Abstract][Full Text] [Related]
7.
Demaria L; Borie R; Benali K; Piekarski E; Goossens J; Palazzo E; Forien M; Dieudé P; Crestani B; Ottaviani S
Clin Rheumatol; 2020 Sep; 39(9):2727-2734. PubMed ID: 32198555
[TBL] [Abstract][Full Text] [Related]
8. [Sarcoidosis demonstrated by fluorodeoxyglucose positron emission tomography in a case of granulomatous myopathy].
Dufour JF; Billotey C; Streichenberger N; Bouhour F; Broussolle C; Sève P
Rev Med Interne; 2007 Aug; 28(8):568-70. PubMed ID: 17445952
[TBL] [Abstract][Full Text] [Related]
9. Bone and bone marrow involvement in sarcoidosis.
Yachoui R; Parker BJ; Nguyen TT
Rheumatol Int; 2015 Nov; 35(11):1917-24. PubMed ID: 26248533
[TBL] [Abstract][Full Text] [Related]
10. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
[TBL] [Abstract][Full Text] [Related]
11. F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography/computed tomography imaging in a case of neurosarcoidosis.
Kim SK; Im HJ; Kim W; Kim TS; Hwangbo B; Kim HJ
Clin Nucl Med; 2010 Feb; 35(2):67-70. PubMed ID: 20090446
[TBL] [Abstract][Full Text] [Related]
12. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis.
Ishimaru S; Tsujino I; Takei T; Tsukamoto E; Sakaue S; Kamigaki M; Ito N; Ohira H; Ikeda D; Tamaki N; Nishimura M
Eur Heart J; 2005 Aug; 26(15):1538-43. PubMed ID: 15809286
[TBL] [Abstract][Full Text] [Related]
13. Diffuse renal (18)F-FDG uptake of a patient with fever of unknown origin revealed sarcoidosis.
Toyonaga T; Manabe O; Gaertner FC; Nakagaki T; Nishio S; Suzuki A; Tamaki N
Clin Nucl Med; 2014 Jul; 39(7):648-9. PubMed ID: 24873783
[TBL] [Abstract][Full Text] [Related]
14. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET.
Yamagishi H; Shirai N; Takagi M; Yoshiyama M; Akioka K; Takeuchi K; Yoshikawa J
J Nucl Med; 2003 Jul; 44(7):1030-6. PubMed ID: 12843216
[TBL] [Abstract][Full Text] [Related]
15. The scar sign: a useful finding on FDG PET/CT to distinguish sarcoidosis from other causes of lymphadenopathy.
Lu SJ; Lee VK; Loo SW
Clin Nucl Med; 2013 Mar; 38(3):205-8. PubMed ID: 23354040
[TBL] [Abstract][Full Text] [Related]
16. Fluorodeoxyglucose positron emission tomography for the diagnosis of sarcoidosis in patients with unexplained chronic uveitis.
Seve P; Billotey C; Janier M; Grange JD; Broussolle C; Kodjikian L
Ocul Immunol Inflamm; 2009; 17(3):179-84. PubMed ID: 19585360
[TBL] [Abstract][Full Text] [Related]
17. Sarcoid-like reaction to malignancy on whole-body integrated (18)F-FDG PET/CT: prevalence and disease pattern.
Chowdhury FU; Sheerin F; Bradley KM; Gleeson FV
Clin Radiol; 2009 Jul; 64(7):675-81. PubMed ID: 19520211
[TBL] [Abstract][Full Text] [Related]
18. FDG PET for gauging of sarcoid disease activity.
Adams H; Keijsers RG; Korenromp IH; Grutters JC
Semin Respir Crit Care Med; 2014 Jun; 35(3):352-61. PubMed ID: 25007087
[TBL] [Abstract][Full Text] [Related]
19. The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma.
Muslimani AA; Farag HL; Francis S; Spiro TP; Chaudhry AA; Chan VC; Taylor HC; Daw HA
Am J Clin Oncol; 2008 Oct; 31(5):409-12. PubMed ID: 18838874
[TBL] [Abstract][Full Text] [Related]
20. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.
Teirstein AS; Machac J; Almeida O; Lu P; Padilla ML; Iannuzzi MC
Chest; 2007 Dec; 132(6):1949-53. PubMed ID: 17925421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]